• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对近期研发的抗生素的评估。

An evaluation of recently developed antibiotics.

作者信息

Fernandes C J, Stevens D A, Murray S I, Ackerman V P

出版信息

J Antimicrob Chemother. 1983 Dec;12(6):577-85. doi: 10.1093/jac/12.6.577.

DOI:10.1093/jac/12.6.577
PMID:6662836
Abstract

A number of newer antibiotics, broad-spectrum penicillins and cephalosporins, have been evaluated against Gram-negative rods. The organisms were selected for multi-resistance and transferable resistance factors. None of the broad-spectrum penicillins was much use against most of the organisms. Ceftriaxone, cefotaxime, latamoxef (moxalactam) and N-formimidoyl thienamycin were all highly effective against most multi-resistant Gram-negative bacilli; cefoperazone being inferior to them. Enterobacter and Serratia strains were relatively resistant to all the agents mentioned and against Acinetobacter only N-formimidoyl thienamycin showed much activity. Thus, use of these drugs may increase the proportion of infections due to organisms such as Serratia or Acinetobacter.

摘要

已对多种新型抗生素、广谱青霉素和头孢菌素针对革兰氏阴性杆菌进行了评估。所选菌株具有多重耐药性和可转移的耐药因子。大多数广谱青霉素对大多数此类菌株作用不大。头孢曲松、头孢噻肟、拉氧头孢(羟羧氧酰胺菌素)和N-甲脒硫霉素对大多数多重耐药革兰氏阴性杆菌均非常有效;头孢哌酮则次之。肠杆菌属和沙雷氏菌属菌株对上述所有药物相对耐药,而对于不动杆菌属,只有N-甲脒硫霉素显示出较强活性。因此,使用这些药物可能会增加由沙雷氏菌属或不动杆菌属等菌株引起的感染比例。

相似文献

1
An evaluation of recently developed antibiotics.对近期研发的抗生素的评估。
J Antimicrob Chemother. 1983 Dec;12(6):577-85. doi: 10.1093/jac/12.6.577.
2
In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.与羟羧氧酰胺菌素和头孢噻肟相比,N-甲脒硫霉素对庆大霉素耐药革兰氏阴性菌的体外活性
Eur J Clin Microbiol. 1982 Feb;1(1):49-51. doi: 10.1007/BF02014140.
3
Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.对第三代头孢菌素耐药的革兰氏阴性杆菌:β-内酰胺酶特性及对Sch 34343的敏感性
J Antimicrob Chemother. 1985 Jun;15 Suppl C:119-32. doi: 10.1093/jac/15.suppl_c.119.
4
A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.N-甲酰亚胺基硫霉素(MK0787)与其他近期研发的β-内酰胺衍生物抗菌活性的比较。
Antimicrob Agents Chemother. 1982 Aug;22(2):302-7. doi: 10.1128/AAC.22.2.302.
5
Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.N-甲酰亚胺硫霉素与第三代头孢菌素及脲基青霉素对多重耐药粘质沙雷菌的比较活性
Microbiol Immunol. 1981;25(11):1119-27. doi: 10.1111/j.1348-0421.1981.tb00120.x.
6
Sensitivity of 523 blood culture isolates to 33 antibiotics.
Scand J Infect Dis. 1984;16(1):61-71. doi: 10.3109/00365548409068410.
7
In vitro comparative activity of moxalactam, GR 20263, and N-formimidoyl thienamycin to other beta-lactam antibiotics and tobramycin against enterobacteriaceae and staphylococci.羟羧氧酰胺菌素、GR 20263和N-甲酰亚胺基硫霉素与其他β-内酰胺类抗生素及妥布霉素对肠杆菌科细菌和葡萄球菌的体外比较活性。
Chemotherapy. 1982;28(3):204-8. doi: 10.1159/000238077.
8
[Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].头孢曲松、头孢噻肟和拉氧头孢对150株革兰氏阴性菌的比较研究(作者译)
Pathol Biol (Paris). 1982 Jun;30(6):341-4.
9
Cefoperazone against carbenicillin-resistant isolates of Pseudomonas aeruginosa: comparison with other newer cephalosporins and N-formimidoyl thienamycin.头孢哌酮对耐羧苄西林铜绿假单胞菌分离株的作用:与其他新型头孢菌素及N-甲酰亚胺硫霉素的比较
J Antimicrob Chemother. 1983 Oct;12(4):337-45. doi: 10.1093/jac/12.4.337.
10
[Comparative in vitro activity of 6 recent beta-lactams against hospital strains of Acinetobacter calcoaceticus: role of the monobactam SQ 26,776].6种新型β-内酰胺类药物对医院分离的醋酸钙不动杆菌菌株的体外比较活性:单环β-内酰胺类药物SQ 26,776的作用
Pathol Biol (Paris). 1983 May;31(5):392-5.

引用本文的文献

1
Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.头孢曲松。对其抗菌活性、药理特性及治疗用途的综述。
Drugs. 1984 Jun;27(6):469-527. doi: 10.2165/00003495-198427060-00001.
2
Ceftriaxone: a three centre comparative in vitro susceptibility study.
Eur J Clin Microbiol. 1985 Apr;4(2):142-4. doi: 10.1007/BF02013584.
3
Relationship between the bactericidal and bacteriolytic activity of cephalosporins and changes in the cell volumes of Escherichia coli cultures.头孢菌素的杀菌和溶菌活性与大肠杆菌培养物细胞体积变化之间的关系
Infection. 1985 Sep-Oct;13(5):235-9. doi: 10.1007/BF01667219.
4
Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.亚胺培南/西司他丁。对其抗菌活性、药代动力学特性及治疗效果的综述。
Drugs. 1987 Mar;33(3):183-241. doi: 10.2165/00003495-198733030-00001.
5
Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.奈替米星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1989 Nov;38(5):703-56. doi: 10.2165/00003495-198938050-00003.